Asterias Biotherapeu
AST
Delayed Nyse MKT - 10/20 10:00:00 pm
2.75USD
-1.79%
Upcoming events

- No events available -

Past Events
09/27/17 | 07:40pmCantor Fitzgerald Global Healthcare Conference
09/11/17 | 09:25pmRodman & Renshaw Global Investment Conference
08/14/17 | 10:30pmInterim 2017 Earnings Call
08/14/17Interim 2017 Earnings Release
Annual results
Annual results20162017 (e)
Sales
Million $
Released
Forecast
Spread
6,95
7,78
-11%

4,29
Operating income (EBITDA)
Million $
Released
Forecast
Spread
-30,3
-30,4
0,46%

-30,3
Operating profit (EBIT)
Million $
Released
Forecast
Spread
-34,1
-33,4
-2,0%

-32,7
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
-37,8
-35,5
-6,5%

-30,5
Net income
Million $
Released
Forecast
Spread
-35,5
-32,9
-7,9%

-30,1
EPS
 $
Released
Forecast
Spread
-0,83
-0,77
-7,3%

-0,60
Announcement Date03/28/2017
Quarterly / Semiannualy publications
Quarterly resultsQ2
2017
Q3
2017 (e)
Sales
Million $
Released
Forecast
Spread
0,32
1,41
-78%

1,48
Operating income (EBITDA)
 
Released
Forecast
Spread




Operating profit (EBIT)
Million $
Released
Forecast
Spread
-8,53
-9,05
5,7%

-7,03
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
-8,73
-9,10
4,1%

-7,45
Net income
Million $
Released
Forecast
Spread
-8,73
-8,90
1,9%

-7,30
EPS
 $
Released
Forecast
Spread
-0,18
-0,18
0,94%

-0,15
Announcement Date08/14/2017